Clinical data | Case identification number | Mean ± SD | |||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | ||
Postoperative complicationsa | UTI, pain | UTI | UTI, pain | pain | – | UTI | – |
Postoperative hospital stays, days | 10 | 16 | 11 | 10 | 12 | 14 | 12 ± 2 |
MAP at 2 h after operation, mmHg | 89 | 85 | 94 | 85 | 112 | 94 | 93 ± 10 |
MAP on the first postoperative day, mmHg | 87 | 72 | 85 | 78 | 99 | 80 | 84 ± 9 |
MAP on the second postoperative day, mmHg | 94 | 82 | 93 | 84 | 97 | 76 | 88 ± 8 |
MAP on the third postoperative day, mmHg | 87 | 93 | 91 | 88 | 104 | 77 | 90 ± 9 |
ΔMAPb, mmHg | 4 | − 5 | − 3 | − 9 | − 7 | − 5 | − 4 ± 4 |
Urine volume on the first postoperative day, ml | 1070 | 2400 | 2020 | 2050 | 1700 | 2550 | 1965 ± 532 |
ΔUrine volumec, ml | 220 | 700 | 370 | 250 | 400 | 850 | 465 ± 254 |
Scr at 24 h after operation, µ mol/L | 118 | 151 | 100 | 76 | 95 | 108 | 108 ± 25 |
Scr at 3 days after the operation, µ mol/L | 70 | 140 | 95 | 79 | 77 | 62 | 87 ± 28 |
Scr at 7 days after the operation, µ mol/L | 57 | 110 | 91 | 82 | 72 | 58 | 78 ± 20 |
Scr at 1 month after the operation, µ mol/L | 59 | 92 | 88 | 67 | 61 | 59 | 71 ± 15 |
Scr at 12 months after the operation, µ mol/L | 80 | 103 | 84 | 62 | 61 | 65 | 76 ± 16 |
ΔScr 1d, µ mol/L | 9 | 11 | 28 | 6 | 2 | 3 | 10 ± 10 |
ΔScr 12e, µ mol/L | 30 | 22 | 24 | 1 | 2 | 9 | 15 ± 12 |
PI at 1 month after the operation | 0.95 | 1.54 | 1.23 | 1.24 | 1.05 | 0.99 | 1.17 ± 0.22 |
RI at 1 month after the operation | 0.57 | 0.78 | 0.71 | 0.7 | 0.62 | 0.59 | 0.66 ± 0.08 |
Tumor recurrence or metastasis | – | – | graft removal | – | – | – | – |
Hospitalization expenses, yuan (RMB) | 44,989 | 54,713 | 43,612 | 49,542 | 49,773 | 37,715 | 46,724 ± 5915 |